ATE356608T1 - Behandlung der multiplen sklerose durch einnahme von copolymer-1 - Google Patents
Behandlung der multiplen sklerose durch einnahme von copolymer-1Info
- Publication number
- ATE356608T1 ATE356608T1 AT98901745T AT98901745T ATE356608T1 AT E356608 T1 ATE356608 T1 AT E356608T1 AT 98901745 T AT98901745 T AT 98901745T AT 98901745 T AT98901745 T AT 98901745T AT E356608 T1 ATE356608 T1 AT E356608T1
- Authority
- AT
- Austria
- Prior art keywords
- treatment
- multiple sclerosis
- copolymer
- taking
- taking copolymer
- Prior art date
Links
- 201000006417 multiple sclerosis Diseases 0.000 title abstract 2
- 230000037406 food intake Effects 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/02—Peptides of undefined number of amino acids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Epidemiology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Materials For Medical Uses (AREA)
- General Preparation And Processing Of Foods (AREA)
- Treatments Of Macromolecular Shaped Articles (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IL11998997A IL119989A0 (en) | 1997-01-10 | 1997-01-10 | Pharmaceutical compositions for oral treatment of multiple sclerosis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE356608T1 true ATE356608T1 (de) | 2007-04-15 |
Family
ID=11069682
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT98901745T ATE356608T1 (de) | 1997-01-10 | 1998-01-12 | Behandlung der multiplen sklerose durch einnahme von copolymer-1 |
Country Status (18)
| Country | Link |
|---|---|
| EP (1) | EP0975351B1 (cs) |
| JP (1) | JP4216342B2 (cs) |
| KR (1) | KR20000070058A (cs) |
| CN (1) | CN100528222C (cs) |
| AT (1) | ATE356608T1 (cs) |
| AU (1) | AU737287B2 (cs) |
| BR (1) | BRPI9807076B8 (cs) |
| CA (1) | CA2277365C (cs) |
| CZ (1) | CZ297983B6 (cs) |
| DE (1) | DE69837324T2 (cs) |
| EA (1) | EA003128B1 (cs) |
| HU (1) | HU226612B1 (cs) |
| IL (2) | IL119989A0 (cs) |
| NZ (1) | NZ336690A (cs) |
| PL (1) | PL193300B1 (cs) |
| SK (1) | SK284029B6 (cs) |
| WO (1) | WO1998030227A1 (cs) |
| ZA (1) | ZA98214B (cs) |
Families Citing this family (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2003521448A (ja) * | 1998-07-23 | 2003-07-15 | ザ・プレジデント・アンド・フェローズ・オブ・ハーバード・カレッジ | 合成ペプチドおよび自己免疫疾患治療のための使用方法 |
| WO2000005250A1 (en) | 1998-07-23 | 2000-02-03 | Yeda Research And Development Co., Ltd | Treatment of autoimmune conditions with copolymer 1 and related copolymers and peptides |
| ES2527760T3 (es) | 1998-07-23 | 2015-01-29 | Yeda Research And Development Co., Ltd. | Tratamiento de enfermedad de Crohn con copolímero 1 y polipéptidos |
| US6800287B2 (en) | 1998-09-25 | 2004-10-05 | Yeda Research And Development Co., Ltd. | Copolymer 1 related polypeptides for use as molecular weight markers and for therapeutic use |
| EP1187612B1 (en) * | 1999-06-04 | 2005-01-26 | Vereniging Voor Christelijk Wetenschappelijk Onderwijs | Use of riluzole for the treatment of multiple sclerosis |
| US6872739B1 (en) * | 1999-06-04 | 2005-03-29 | Vereniging Voor Christelijk Wetenshappelikjk Onderwijs | Use of riluzole for the treatment of multiple sclerosis |
| JP2003522799A (ja) * | 2000-02-18 | 2003-07-29 | イエダ・リサーチ・アンド・ディベロップメント・カンパニー・リミテッド・アット・ザ・ウェイズマン・インスティテュート・オブ・サイエンス | コポリマー１の経口、経鼻および経肺投与製剤 |
| ZA200206457B (en) | 2000-02-18 | 2003-08-13 | Yeda Res & Dev | Oral, nasal and pulmonary dosage formulations of copolymer 1. |
| PL363431A1 (en) * | 2000-06-05 | 2004-11-15 | Teva Pharmaceuticals Industries, Ltd. | The use of glatiramer acetate (copolymer 1) in the treatment of central nervous system disorders |
| US20020077278A1 (en) | 2000-06-05 | 2002-06-20 | Yong V. Wee | Use of glatiramer acetate (copolymer 1) in the treatment of central nervous system disorders |
| WO2002076503A1 (en) | 2000-06-20 | 2002-10-03 | Mayo Foundation For Medical Education And Research | Treatment of central nervous system diseases by antibodies against glatiramer acetate |
| CA2469393C (en) | 2001-12-04 | 2010-05-25 | Teva Pharmaceutical Industries, Ltd. | Processes for the measurement of the potency of glatiramer acetate |
| SI1485127T1 (sl) | 2002-02-25 | 2011-09-30 | Elan Pharm Inc | Dajanje aktivne snovi za zdravljenje vnetja |
| UY28170A1 (es) * | 2003-01-24 | 2004-07-30 | Elan Pharm Inc | Preparacion y tratamiento para las enfermedades desmielinizantes y paralisis mediante la aplicacion de agentes remielinizantes. |
| DK1797109T3 (en) | 2004-09-09 | 2016-04-11 | Yeda Res & Dev | MIXTURES OF POLYPEPTIDES, compositions containing them and methods for their preparation, and uses thereof |
| SG10201405806SA (en) | 2009-08-20 | 2014-11-27 | Yeda Res & Dev | Low Frequency Glatiramer Acetate Therapy |
| USRE49251E1 (en) | 2010-01-04 | 2022-10-18 | Mapi Pharma Ltd. | Depot systems comprising glatiramer or pharmacologically acceptable salt thereof |
| US8759302B2 (en) | 2010-03-16 | 2014-06-24 | Teva Pharmaceutical Industries, Ltd. | Methods of treating a subject afflicted with an autoimmune disease using predictive biomarkers of clinical response to glatiramer acetate therapy in multiple sclerosis |
| ES2602977T3 (es) | 2010-10-11 | 2017-02-23 | Teva Pharmaceutical Industries Ltd. | Biomarcadores de citocinas como biomarcadores predictivos de la respuesta clínica para acetato de glatirámero |
| AU2012323345A1 (en) | 2011-10-10 | 2014-05-22 | Teva Pharmaceutical Industries Ltd. | Single nucleotide polymorphisms useful to predict clinical response for glatiramer acetate |
| MX2015004563A (es) | 2012-10-10 | 2015-07-14 | Teva Pharma | Biomarcadores predictivos para respuesta clinica para acetato de glatiramero. |
| UY35790A (es) | 2013-10-21 | 2015-05-29 | Teva Pharma | Marcadores genéticos que predicen la respuesta al acetato de glatiramer |
| CN105884866B (zh) * | 2015-01-26 | 2021-04-20 | 漳州未名博欣生物医药有限公司 | 格拉替雷的化学合成方法 |
| US9155775B1 (en) | 2015-01-28 | 2015-10-13 | Teva Pharmaceutical Industries, Ltd. | Process for manufacturing glatiramer acetate product |
| EP3603764B1 (en) * | 2015-04-28 | 2022-03-30 | Hybio Pharmaceutical Co., Ltd. | High performance liquid chromatography method for polypeptide mixtures |
| US12097292B2 (en) | 2016-08-28 | 2024-09-24 | Mapi Pharma Ltd. | Process for preparing microparticles containing glatiramer acetate |
| CN109982712A (zh) | 2016-08-31 | 2019-07-05 | Mapi医药公司 | 包含醋酸格拉替雷的储库系统 |
| BR112019017724A2 (pt) | 2017-03-26 | 2020-03-31 | Mapi Pharma Ltd. | Sistemas depot de glatiramer para tratar formas progressivas de esclerose múltipla |
| WO2019002228A1 (en) | 2017-06-26 | 2019-01-03 | Institut Pasteur | TREATMENTS TO REMOVE HIV RESERVOIRS AND REDUCE VIRAL LOAD |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL113812A (en) * | 1994-05-24 | 2000-06-29 | Yeda Res & Dev | Copolymer-1 pharmaceutical compositions containing it and its use |
| US5719296A (en) * | 1995-10-30 | 1998-02-17 | Merck & Co., Inc. | Pseudopeptide lactam inhibitors of peptide binding to MHC class II proteins |
-
1997
- 1997-01-10 IL IL11998997A patent/IL119989A0/xx unknown
-
1998
- 1998-01-12 ZA ZA9800214A patent/ZA98214B/xx unknown
- 1998-01-12 CZ CZ0243799A patent/CZ297983B6/cs not_active IP Right Cessation
- 1998-01-12 AU AU58195/98A patent/AU737287B2/en not_active Expired
- 1998-01-12 CA CA2277365A patent/CA2277365C/en not_active Expired - Lifetime
- 1998-01-12 BR BRPI9807076A patent/BRPI9807076B8/pt not_active IP Right Cessation
- 1998-01-12 HU HU0001917A patent/HU226612B1/hu unknown
- 1998-01-12 KR KR1019997006278A patent/KR20000070058A/ko not_active Ceased
- 1998-01-12 EA EA199900621A patent/EA003128B1/ru not_active IP Right Cessation
- 1998-01-12 CN CNB988031221A patent/CN100528222C/zh not_active Expired - Lifetime
- 1998-01-12 PL PL334566A patent/PL193300B1/pl unknown
- 1998-01-12 WO PCT/US1998/000375 patent/WO1998030227A1/en not_active Ceased
- 1998-01-12 NZ NZ336690A patent/NZ336690A/en not_active IP Right Cessation
- 1998-01-12 AT AT98901745T patent/ATE356608T1/de not_active IP Right Cessation
- 1998-01-12 DE DE69837324T patent/DE69837324T2/de not_active Expired - Lifetime
- 1998-01-12 EP EP98901745A patent/EP0975351B1/en not_active Expired - Lifetime
- 1998-01-12 SK SK931-99A patent/SK284029B6/sk not_active IP Right Cessation
- 1998-01-12 JP JP53110898A patent/JP4216342B2/ja not_active Expired - Lifetime
-
1999
- 1999-07-06 IL IL130820A patent/IL130820A/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| CN1249690A (zh) | 2000-04-05 |
| IL119989A0 (en) | 1997-04-15 |
| SK93199A3 (en) | 2000-11-07 |
| NZ336690A (en) | 2001-05-25 |
| EA199900621A1 (ru) | 2000-02-28 |
| BRPI9807076B8 (pt) | 2021-05-25 |
| PL334566A1 (en) | 2000-03-13 |
| JP4216342B2 (ja) | 2009-01-28 |
| JP2001511121A (ja) | 2001-08-07 |
| AU5819598A (en) | 1998-08-03 |
| CZ243799A3 (cs) | 2000-06-14 |
| HUP0001917A2 (hu) | 2000-10-28 |
| BR9807076A (pt) | 2000-05-02 |
| EP0975351A1 (en) | 2000-02-02 |
| EA003128B1 (ru) | 2003-02-27 |
| CA2277365A1 (en) | 1998-07-16 |
| CN100528222C (zh) | 2009-08-19 |
| EP0975351B1 (en) | 2007-03-14 |
| CA2277365C (en) | 2011-04-12 |
| BR9807076B1 (pt) | 2013-10-29 |
| EP0975351A4 (en) | 2002-05-15 |
| HU226612B1 (en) | 2009-04-28 |
| SK284029B6 (sk) | 2004-08-03 |
| DE69837324D1 (de) | 2007-04-26 |
| ZA98214B (en) | 1999-08-11 |
| AU737287B2 (en) | 2001-08-16 |
| HK1025737A1 (en) | 2000-11-24 |
| DE69837324T2 (de) | 2007-11-29 |
| KR20000070058A (ko) | 2000-11-25 |
| WO1998030227A1 (en) | 1998-07-16 |
| IL130820A (en) | 2007-03-08 |
| PL193300B1 (pl) | 2007-01-31 |
| HUP0001917A3 (en) | 2001-12-28 |
| CZ297983B6 (cs) | 2007-05-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69837324D1 (de) | Behandlung der multiplen sklerose durch einnahme von copolymer-1 | |
| DK0705100T3 (da) | Terapeutiske substituerede guanidiner | |
| SE9200951D0 (sv) | Pharmaceutical composition containing a defined lipid system | |
| DE69326250D1 (de) | Neuropeptide y antagoniste | |
| IS4695A (is) | (Metýlsúlfónýl)fenýl-2-(5H)-fúranón sem sýklóoxýgenasa-2 tálmar | |
| DE69533264D1 (de) | Inhibitoren der il-6 aktivitaet | |
| DK1465626T3 (da) | Farmaceutiske præparater (kit) der omfatter dihydropyridinonforbindelser og et immunregulatorisk (eller et antiinflammatorisk) middel samt anvendelser deraf | |
| ATE423562T1 (de) | Alpha-ketoamidhaltige multikatalytische protease inhibitoren | |
| EA199900239A1 (ru) | Замещенные n-[аминоиминометил или аминометил) фенил] пропиламиды | |
| DE69830751D1 (de) | Polyaromatische Verbindungen zur Behandlung von Herpes-Infektionen | |
| NO974147D0 (no) | Heterocykelkarbonyl aminosyre hydroksyetylamino sulfonamid retroviral protease | |
| KR960006915A (ko) | 췌장염의 치료 조성물 | |
| DE69820053D1 (de) | Stör-notokord zur verminderung der symptome / behandlung von arthritis | |
| DE69804865D1 (de) | Feste miltefosin enthaltende arzneimittel zur oralen verabreichung bei der behandlung von leishmaniasis | |
| TR200402070T4 (tr) | Siklobüten-dion türevleri ve bunların damar sertliği tedavisinde kullanımı | |
| GB2331926A (en) | Pharmaceutical compositions containing ibuprofen and domperidone for the treatment of migraine | |
| ATE305517T1 (de) | Neurotrypsin | |
| DE60113664D1 (de) | Zusammensetzung zur behandlung von herzinsuffizienz | |
| ATE309803T1 (de) | Sphingomyelinase inhibitoren als wirkstoffe mit antiapoptotischer und antiseptischer wirkung | |
| ATE141248T1 (de) | Neue bis-phenyl-hexene | |
| DK0539465T3 (da) | Anvendelse af 20(R)-22-oxa-D-vitamin-analoger til fremstilling af et farmaceutisk præparat til behandling og/eller forebyggelse af hudaldring | |
| ATE276272T1 (de) | Entzündungshemmende peptide | |
| RU93055680A (ru) | Ингибиторы вич-протеазы, способ получения, их использование, композиция | |
| RU93055683A (ru) | Ингибиторы вич-протеазы, способ их получения, их использование, композиция | |
| RU93045696A (ru) | Ингибиторы протеазы вируса иммунодефицита человека, полезные для лечения спида |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |